Three antimalarial drugs are available for the treatment of systemic lupus erythematosus (SLE): hydroxychloroquine (HCQ), chloroquine (CQ), and quinacrine (Qn).
Treatment of SLE. Nonsteroidal anti-inflammatory drugs (NSAIDs) in addition to antimalarials for mild disease. Corticosteroids, immunosuppressants, and
(0.12MB). Antimalarials, chloroquine and hydroxychloroquine, are first line drugs for the treatment of SLE due to their capacity to prevent relapses
by N Rothfield 2024 Cited by 45No recent study has been published on the efficacy of antimalarial drugs in the treatment of systemic lupus erythematosus (SLE). However, antimalarial drug
Overall, antimalarial drugs have numerous beneficial effects in patients with SLE and lupus nephritis, and have a good safety profile.
by Y Tanaka 2024 Cited by 4For the treatment of SLE, hydroxychloroquine, the antimalarial drug, is recommended as a standard drug for all patients with fewer
This led to research confirming the effectiveness of antimalarial drugs in the treatment of systemic lupus erythematosus (SLE). In 2024, HCQ
This led to research confirming the effectiveness of antimalarial drugs in the treatment of systemic lupus erythematosus (SLE). In 2024, HCQ was
Antimalarial agents. In every patient with SLE treatment with antimalarials is recommended unless there are contraindications (21 23). The action of antimalarials is based on, among other factors, the inhibition of activation of intracellular toll-like receptors . Hydroxychloroquine and chloroquine are licensed for the treatment of SLE.
Comments
LWlurker